News
A study by researchers at Rutgers Health has uncovered a way to precisely identify and target trauma sites in the body within ...
The growth of the global epigenetics market is attributed to increase in oncology cases, surge of other chronic diseases and its rising application for non-oncology applications.” — Allied Market ...
A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to ...
Notably, prior to the appointments of Kelly and Aromando, Oncolytics presented new GOBLET data at the 2025 ASCO Annual ...
NEW YORK, NY, UNITED STATES, June 30, 2025 /EINPresswire.com/ -- JessZilla, the award-winning documentary following the life ...
AstraZeneca and its partner Daiichi Sankyo have won approval from U.S. regulators for their precision drug Datroway to treat ...
Altogether, GE HealthCare has the unique ability to provide solutions along every step of the theranostics care pathway. Our integrated portfolio of solutions provides clinicians with the isotopes, ...
The pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its potential for harsh side effects. There is still more work to be done to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results